Blood Test For Ovarian Cancer
Ovarian cancer, the leading cause of gynecologic cancer deaths in the U.S. and 3 times more lethal than breast cancer, is usually not diagnosed until its advanced stages. Clinicians currently have no sensitive screening method because the disease shows few symptoms in its early stages.
David Ward and colleagues developed and tested a blood test for ovarian cancer based on four proteins: leptin, prolactin, osteopontin, and insulin-like growth factor-II. If the level of two or more of these biomarkers for a patient falls within a certain range, the test will predict that a tumor is present. In a test group of more than 200 healthy women and women with ovarian cancer, the test showed 95% sensitivity (fraction correctly diagnosed with cancer) and 95% specificity (fraction correctly diagnosed as cancer-free). Each of the proteins had been previously suggested as an accurate cancer biomarker, though not as a set. In this study, no single protein could completely distinguish the cancer patients from healthy control individuals.
PNAS highlights for the week of May 9 - 13
The Proceedings of the National Academy of Sciences (PNAS) is the multi-disciplinary, peer-reviewed journal of the National Academy of Sciences. Founded in 1914, PNAS publishes daily online and weekly in print. The preceding highlights are not intended to substitute for articles as sources of information. The articles in PNAS report original research by independent authors and do not necessarily represent the views of the National Academy of Sciences or the National Research Council.
Contact: Leikny Johnson
PNASNews@nas.edu
202-334-1310
Proceedings of the National Academy of Sciences (PNAS)
http://www.pnas.org
Test de sânge pentru cancerul ovarian - Blood Test For Ovarian Cancer - articole medicale engleza - startsanatate